Russel Reiter to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Russel Reiter has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.164
-
Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res. 2018 Apr; 64(3).
Score: 0.084
-
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. Int J Mol Sci. 2017 Apr 17; 18(4).
Score: 0.080